. Membrane targeting of WAVE2 is not sufficient for WAVE2-dependent actin polymerization: a role for IRSp53 in mediating the interaction between Rac and WAVE2.
Introduction
Fascin is an actin-bundling protein expressed by normal mesenchymal, neuronal and dendritic cells that contributes to the assembly of cortical cell protrusions and filopodia (reviewed by Kureishy et al., 2002; Adams, 2004) . Most normal epithelia are negative for fascin; however, upregulation of fascin is frequently associated with a poor prognosis in human carcinomas and is implicated in metastasis (Pelosi et al., 2003; Hashimoto et al., 2004; Hashimoto et al., 2006; Yoder et al., 2005; Zigeuner et al., 2006; Puppa et al., 2007) . We have recently demonstrated that fascin expression by human colon carcinoma cells contributes to assembly of filopodia, focal adhesion dynamics and cell migration in culture, and tumour development and metastasis in vivo (Hashimoto et al., 2007) . We also found that the role of fascin in carcinoma migration is dependent on Rac activity. Rac GTPase is a well-established regulator of actin polymerisation that, via its effector p21-activated kinase, activates Lim kinase to inactivate cofilin (Machesky and Hall, 1997; Hartwig et al., 1995; Yang et al., 1998) . These mechanisms impact on the availability of F-actin, which is a prerequisite for F-actin bundling by fascin (Edwards and Bryan, 1995; Adams and Schwartz, 2000) .
Both Rac and Cdc42 are upstream regulators of the organisation of fascin and F-actin in protrusions and ruffles in cells adherent to thrombospondin 1 (Adams and Schwartz, 2000) . Within the Nterminal actin-binding domain of fascin, residue Ser39 (S39) is a target for phosphorylation by protein kinase Cα (PKCα) (Ono et al., 1997) . S39-phosphorylated fascin does not bundle actin, yet interacts with the regulatory domain of active PKCα and contributes to myoblast migration on fibronectin through this interaction (Anilkumar et al., 2003) . The migratory and metastatic capacity of fascin-positive human colon carcinoma cells depend on both the actin-bundling and the active PKC-binding activities of fascin (Hashimoto et al., 2007) . However, whether Rac or Cdc42 regulate the phosphofascin/active PKC interaction is unknown. We have investigated this issue and report here direct evidence for specific regulation of the fascin/PKCγ complex by Rac via a Pak-dependent process.
Results

Colocalisation of PKCγ with fascin in colon carcinoma cells is Rac dependent
Initial experiments established that PKCγ is the predominant conventional PKC isoform in human colon carcinoma cells (see supplementary material Fig. S1 ). These cells express Rac1 (Hashimoto et al., 2007) . Of the other members of the Rac family, Rac2 is restricted to haematopoietic cells (Shirsat et al., 1990) and antibodies specific for Rac3 are unavailable. In this study we will refer to 'Rac1' if reagents of defined specificity were used, and otherwise to 'Rac'. Because the relationship between PKCγ and fascin was unknown, we examined the localisations of endogenous Rac1, fascin and PKCγ in SW480 cells randomly migrating on laminin (LN) surfaces. This experimental setup correlates excellently with carcinoma cell behaviour in vivo (Hashimoto et al., 2007) . Fascin, Rac1 and PKCγ were each present in the cell body and colocalised at protrusive tips and lamellipodial edges ( Fig.  1A 
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PKC activity by bisindolylmaleimide I (BIM) was found to reduce both fascin and PKCγ staining at membrane protrusions (Fig. 1A) , whereas Rac1 remained detectable at cell edges (Fig. 1B, arrows) . By contrast, application of the Rac inhibitor NSC23766 (Gao et al., 2004) , which blocks Rac activation [thereby reducing the pool of Rac-GTP (Hashimoto et al., 2007) (supplementary material Fig.  S2 )], resulted in loss of all three proteins from lamellipodial edges (Fig. 1A,B and insets ). These results demonstrate that endogenous PKC activity impacts on the cellular localisation of fascin in migrating human colon carcinoma cells, and suggest a role for Rac upstream of both fascin and PKCγ.
Rac regulates PKCγ kinase activity by an indirect mechanism
To establish whether the mechanism of Rac-dependent PKCγ relocalisation involved PKCγ kinase activity, we treated cells migrating on LN with BIM, NSC23766 or solvent control, and examined PKCγ activity by immunoblot. Both pharmacological treatments significantly reduced PKCγ activity (Fig. 1C , quantified in 1E). Phorbol ester activation of conventional PKC reversed the effect of Rac inhibition, further supporting the concept that PKC is activated downstream of Rac (Fig. 1C,E (Fig. 1D) . Thus, Rac is functionally upstream of PKCγ and inhibits its kinase activity by an indirect mechanism.
Fascin and active protein kinase Cγ interact in the protrusions of migrating colon carcinoma cells
To examine whether fascin and PKCγ interact in colon carcinoma cells, we turned to fluorescence resonance energy transfer/fluorescence lifetime imaging microscopy (FRET/FLIM), using green fluorescent protein-fascin (GFP-fascin) and PKCγ-monomer red fluorescent protein (PKCγ-mRFP) as the donor and acceptor probes, respectively. This technique allows precise spatial and temporal analysis of protein interactions in intact cells (Parsons et al., 2004; Parsons et al., 2005) . First, in order to establish that fascin can interact with PKCγ, serum-starved quiescent SW480 cells were treated with 1 μM 4-β-phorbol-12, 13-dibutyrate (PDBu) to activate PKCγ directly. Interaction of GFPfascin and PKCγ-mRFP was observed, as measured by time-dependent, statistically significant decreases in GFP donor fluorescent lifetime relative to its lifetime in control cells expressing GFP-fascin alone ( Fig. 2A,B) . This response was not apparent in control, solvent-treated, coexpressing cells, demonstrating the dependence of the interaction on active PKC ( Fig. 2A,B) . The role of the S39 PKCphosphorylation site of fascin in the interaction was established by use of nonphosphorylatable (S39A) and phosphomimetic (S39D) fascin point mutants (reviewed by Kureishy et al., 2002) . In cells stimulated by PDBu, GFPfascin-S39D interacted strongly with PKCγ-mRFP, whereas an interaction of GFP-fascin-S39A was undetectable (Fig.  2C) . Thus, active PKCγ interacts with phosphorylated fascin in SW480 cells.
Next, fascin/PKC interactions were analysed in live SW480 cells migrating on LN. To examine the dynamics of the interaction without overexpression of fascin, these experiments were carried out with SW480 inducible knock-down (IKD)-F11 cells knocked-down for human fascin 1 (IKD-F11 Fas-cells), in which GFPtagged Xenopus tropicalis fascin 1 (GFPXtfascin), which is not susceptible to the short hairpin RNA (shRNA) to human fascin 1 (Hashimoto et al., 2007) , was transiently expressed. The expression level of transfected GFP-Xtfascin in individual cells was similar to that of endogenous fascin in SW480 cells (Fig. 3A) . FRET/FLIM measurements of cells decreases in GFP fluorescent lifetime, indicative of strong protein interaction, were spatially localised at leading edge protrusions and their associated filopodia (Fig. 3B, arrows) .
The fascin/PKCγ interaction in migrating cells depends on PKCγ kinase activity and Rac activity
To further examine the dependence of the fascin/ PKCγ interaction on PKC kinase activity and Rac in migrating cells, we tested the effects of the pharmacological inhibitors of PKC and Rac on the fascin/PKCγ interaction in migrating IKD-F11 Fas-cells reconstituted with GFP-Xtfascin. Whereas control migrating cells co-expressing GFP-Xtfascin and PKCγ-mRFP had strong FRET efficiency, BIMtreated cells showed near-complete inhibition of FRET, indicating that the interaction with fascin depends on active PKCγ (Fig. 4A,B) .
FRET was also almost totally inhibited in NSC23766-treated cells (Fig. 4A,B) . No changes in donor fluorescence lifetime were detected in migrating cells expressing GFPXtfascin alone (Fig. 4A) . To confirm the effect of pharmacological inhibition of PKC by an independent method, we also examined the ability of a kinase-dead form of PKCγ, PKCγ-K380A-mRFP (Rosenberg and Ravid, 2006) , to interact with GFP-Xtfascin in migrating cells. The FRET efficiency was significantly decreased from that obtained with wild-type PKCγ-mRFP, and was essentially at background level (Fig. 4C) . Thus, the fascin/PKCγ interaction depends strictly on active PKCγ.
Rac specifically regulates the fascin/PKCγ interaction
The results obtained with NSC23766 compound had implicated Rac as an upstream regulator of the interaction of fascin and PKCγ at cell edges ( Fig. 1, Fig. 4B ). To corroborate these results by an independent method and to examine the role of Rac in more depth, we examined the effect of dominant-negative N17Rac1 on the fascin/PKCγ interaction in IKD-F11 Fas-cells rescued with GFP-Xtfascin and migrating on laminin. To test whether Rac is a specific regulator of the interaction, the effect of dominant-negative N17Cdc42 was also examined. Cdc42 is another small GTPase regulator of actin nucleation that promotes filopodial assembly and cell migration in normal and cancer cells (Nobes and Hall, 1995; Rohatgi et al., 1999 ; reviewed by Ridley, 2006) . Cdc42 and Rac both regulate the organisation of fascin and F-actin in protrusions of skeletal myoblasts and fibroblasts (Adams and Schwartz, 2000) . In the migrating colon carcinoma cells, N17Rac1-myc caused significant inhibition of the fascin/PKCγ interaction, whereas N17Cdc42-myc had no significant effect (Fig.  5 ). These data demonstrate a specific role of Rac1 as an upstream regulator.
To gain further insight into the mechanism of Rac1 regulation, the impact of either constitutively active V12Rac1 or V12Cdc42 was examined in serum-starved IKD-F11 Fas-cells rescued with GFP-Xtfascin. After serum starvation, the GFP-Xtfascin/PKCγ-mRFP interaction was at a low level with the GFP fluorescent lifetime similar to that in cells expressing GFP-Xtfascin alone (Fig. 6A,B) . Expression of the active GTPases induced the expected characteristic changes in cell shape, with multiple protrusions and short filopodia in the cells expressing V12Rac1-HA (influenza haemagglutinin tag) and a hyper-filopodial morphology in cells expressing V12Cdc42-HA (Fig. 6B) . Nevertheless, only V12Rac1-HA significantly activated the fascin/PKCγ interaction, which again was strongest in filopodia ( Fig. 6B , and quantified from three independent experiments in Fig.  6C ). Together with the analysis of the effects of the dominantnegative forms of the GTPases in migrating cells (Fig. 5) , these results definitively establish that Rac1, but not Cdc42, is a positive regulator of the fascin/PKCγ interaction.
Rac regulation can be bypassed by constitutive activation of PKCγ
Conventional PKCs are activated by a complex process involving priming phosphorylation events and subsequent membrane Journal of Cell Science 121 (17) Xtfascin alone (top panels) or GFP-Xtfascin and PKCγ-mRFP (bottom panels) were plated on 15 nM LN for 2 hours. Transfected migrating cells were imaged over time, using FLIM to measure FRET. Panels show intensity multiphoton GFP images from each cell (donor) and, where relevant, an epifluorescence image for mRFP (acceptor) at selected timepoints. Lifetime images are depicted by a pseudocolour scale with red as low lifetime (1.7 nseconds) and blue as high (2.3 nseconds). Arrows indicate examples of strong interaction in filopodia. Representative of a total of nine experiments for control and test cells. Rac regulates PKC and fascin interaction translocation, membrane tethering, and release of autoinhibition in the presence of elevated diacylglycerol and Ca 2+ (Griner and Kazanietz, 2007) . To establish whether signal-dependent plasma membrane localisation of active PKCγ is essential for its interaction with fascin, we tested if constitutively active (A25E) PKCγ would interact with fascin in serum-starved cells. The FRET efficiency of PKCγA25E-mRFP with fascin was significantly increased over that of wild-type PKCγ-mRFP, and was similar to the FRET efficiency in the presence of V12Rac1 (Fig. 6B,C) . Furthermore, the fascin/PKCγA25E interaction was not significantly inhibited by NSC treatment of cells (Fig. 6C) , demonstrating that any basal Rac activity present in this experiment can be bypassed by expression of a constitutively active PKCγ.
Pak participates downstream of Rac to regulate the fascin/PKCγ interaction in migrating cells
Our initial results indicated that Rac activity regulates PKCγ kinase activity by an indirect mechanism (Fig. 1D) . To gain insight into the mechanism downstream of Rac, we examined whether the Rac effector p21-activated kinase (Pak) has a role in regulation of the fascin/PKCγ interaction in migrating cells. The Pak family member Pak1 is expressed in colonic epithelial cells and colorectal adenocarcinomas (Carter et al., 2004) . Pak1 is a wellestablished downstream effector of Rac1 that contributes to cell migration and to other motility processes (reviewed by Jaffer and Chernoff, 2002) . Overexpression of wildtype Pak1 did not significantly alter the efficiency of FRET interaction between GFP-Xtfascin and PKCγ-mRFP in IKD-F11 cells migrating on laminin (Fig. 7A,B) . By contrast, overexpression of the autoinhibitory domain (AID; amino acids 83-149) of Pak1, which inhibits activation of Pak1, 2 and 3 without interfering with other Rac effectors (Zhao et al., 1998) , significantly reduced the efficiency of interaction by about 50% (Fig. 7A,B) . The remaining interacting population of fascin and PKCγ was predominantly localised to punctate regions at both the leading edge and the rear of the cell (Fig. 7A , lifetime image for Pak1-AID-expressing cell). These data indicate that Pak1 participates as an upstream regulator of the fascin/PKCγ interaction. To confirm that this activity of Pak1 is mediated downstream of Rac, we examined endogenous active Pak1 in SW480 cells on laminin in the absence or presence of NSC23766. NSC23766 treatment decreased active Pak1 in laminin-adherent cells, as determined by the amount of T423-phosphorylated Pak1 detected on immunoblots of cell extracts, whereas BIM treatment did not alter Pak1 activity status (Fig. 7C) . Thus, Pak1 activity is regulated downstream of Rac and is not dependent on PKC activity.
Discussion
To our knowledge, these data constitute the first report of regulation of a conventional PKC by Rac. Our data establish that in migrating human colon carcinoma cells PKCγ activation requires Rac activity. The activity status of PKCγ in turn controls the interaction of PKCγ with (phospho)fascin, such that the complex is concentrated spatially in the periphery and filopodia of the migrating cells. Rac regulation of PKCγ kinase activity is indirect and is mediated, at least in part, via p21-activated kinase (PAK). We also demonstrate that Cdc42 activity is not required for the fascin/PKCγ interaction. Conventional PKCs are activated by a complex process that involves priming phosphorylation events in the cytoplasm, and release of autoinhibition and membrane translocation in response to increased concentrations of intracellular Ca 2+ and diacylglycerol (Griner and Kazanietz, 2007) . We have established by pharmacological inhibition and with kinase-dead and constitutively active mutant forms of PKCγ that formation of the fascin/PKCγ complex depends crucially on PKCγ kinase activity. Fascin is a substrate of PKC (Ono et al., 1997) and we have identified that a phosphomimetic form of fascin interacts preferentially with active PKCγ. Previously, we mapped the phosphofascin binding site to the regulatory domain of PKCα (Anilkumar et al., 2003) . Thus, phosphorylation of fascin by a conventional PKC is needed for the formation of the fascin-active PKC complex. The strong interaction of fascin with constitutively active PKCγ, which is active independent of a plasma membrane localisation, provides the first demonstration that membrane localisation per se is not crucial for formation of the fascin/PKCγ complex. However, under physiological conditions of cell adhesion and migration on laminin, the interaction of active PKCγ and fascin is concentrated at cell edges and in filopodia. Integrin ligation at sites of adhesion is a strong stimulus for activation of conventional PKCs (reviewed by Berrier and Yamada, 2007) . Extracellular matrix ligation of integrins also regulates Rac and PAK activities (del Pozo et al., 2000) . Thus, extracellular matrix-activated integrin complexes could provide a mechanism to bring active PKCγ and fascin into close proximity with active Rac and PAK, which then act locally to promote PKCγ binding to fascin.
PKC activity is implicated in tumour migration and invasion but the mechanisms remain poorly understood (Griner and Kazanietz, 2007) . Our data establish that PKCγ activity in colon carcinoma cells is indirectly regulated by Rac and identify a PAK, probably Pak1, as a component of the mechanism. Interestingly, Pak1 expression is increased in correlation with malignant progression in several forms of human carcinoma, including colorectal carcinoma (Carter et al., 2004; Holm et al., 2006; Ching et al., 2007; O'Sullivan et al., 2007) . In breast carcinomas, Pak1 overexpression correlates with tamoxifen insensitivity of oestrogen receptorpositive tumours (Holm et al., 2006; Bostner et al., 2007) . In colorectal cancers, Pak1 expression was noted to be significantly higher in lymph node metastases than in the normal colon, adenomas or primary adenocarcinomas. From a composite scoring of primary tumours and metastases, highest Pak1 expression was found to be correlated with reduced patient survival (Carter et al., 2004) . In several carcinoma xenograft models, Pak1 expression and kinase activity have been functionally linked to cell motility and tumour development (Ching et al., 2007; O'Sullivan et al., 2007) . Thus, Pak1, like fascin (see Introduction), contributes to an aggressive, invasive tumour phenotype. Our data place Pak1 as a component of one of the pathways by which fascin impacts on colon carcinoma cell migration. Because Pak1-AID also inhibits Pak2 and Pak3, our data with this reagent do not rule out the possibility that these PAKs are also involved. A Pak1 kinase-independent cell cycle arrest has also been attributed to Pak1-AID, indicating multiple possible mechanisms for the activity of this inhibitory reagent (Thullberg et al., 2007) .
How Pak1 regulates PKCγ activation and whether this mechanism is direct or indirect remains to be elucidated. A possible candidate effector of Pak1 could be the F-actin severing protein cofilin. LIM kinase and cofilin are important downstream mediators of Pak1 in the control of F-actin dynamics during formation of dendritic spines (Zhao et al., 2006) , axon specification (Jacobs et al., 2007) and lamellipodial protrusion (Delorme et al., 2007) . We speculate that localised control of newly forming protrusions by PAK and cofilin could indirectly drive the interaction of fascin and active PKCγ. Alternatively or additionally, the regulation of myosin IIB phosphorylation by PAK that impacts on myosin filament assembly and cell contractility status could regulate integrin signalling to PKCγ (Even-Faitelson and Ravid, 2006) .
Whereas PAK is clearly an important mediator downstream of Rac for the fascin/active PKCγ complex, our FRET efficiency data demonstrate that inhibition of PAK reduces fascin/PKCγ interaction by around 50%. This contrasts with the complete blockade of the complex that results from pharmacological or dominant-negative Journal of Cell Science 121 (17) Fig. 5 . The fascin-PKCγ interaction depends specifically on Rac1 activity in migrating cells. (A,B) IKD-F11 Fas-cells cultured in doxycycline were transiently transfected with GFP-Xtfascin and PKCγ-mRFP in conjunction with either N17Rac1-myc or N17Cdc42-myc, and allowed to migrate on 15 nM laminin for 6 hours. Cells were fixed and antibody stained to detect the GTPase and imaged using FLIM to measure FRET. Only N17Rac1 inhibited the FRET interaction. Lifetime images are depicted with a pseudocolour scale where red is a low lifetime (1.75 nseconds) and blue is high (2.4 nseconds). Representative of at least eight cells in each sample. (C) Cumulative FRET efficiency graph for cells migrating on laminin, under control conditions or in cells expressing N17Rac1-myc or N17Cdc42-myc. The mean FRET efficiency for each condition is from seven to nine cells per condition and three independent experiments. Rac regulates PKC and fascin interaction inhibition of Rac activity. The residual Rac-dependent, but PAK-independent, fascin-and PKCγ-interacting population appears to have a restricted localisation in punctate structures at the front and rear of migrating cells. Several PAK-independent effector mechanisms of Rac have been identified, including PAKindependent actin polymerisation through formation of a complex containing WAVE and Abi1 (AbouKheir et al., 2008) , and also mechanisms dependent on microtubules (Wittman et al., 2004 ). It will be of future interest to identify which Rac-dependent mechanism parallel to PAK contributes to regulation of the fascin-PKCγ complex. This could potentially explain the observed Rac specificity of regulation.
The demonstration of strong, Rac-dependent fascin/PKCγ interaction in filopodia suggests the existence of an actin-bundling-independent mechanism to localise phosphorylated fascin in filopodia. Although phosphorylated fascin does not bundle F-actin and overexpression of phosphomimetic fascin-S39D or -S39E reduces the assembly of cell protrusions (Ono et al., 1997; Adams et al., 1999; Shonukan et al., 2003; Vignjevic et al., 2006; Hashimoto et al., 2007) , the report that fascinS39E concentrates transiently at protrusive tips in melanoma cells (Vignjevic et al., 2006) is consistent with our direct observations of localised fascin-PKCγ interaction in live migrating colon carcinoma cells. The generality of this localisation in cells of other tissue origins remains to be established.
In conclusion, we have put forward the novel model that fascin impacts on filopodial dynamics by two pathways: (1) the previously described crosslinking of F-actin by non-phosphorylated fascin that leads to the structural organisation of unipolar actin bundles in filopodia and lamellipodial protrusions and is dependent on both Cdc42 and Rac (Adams and Schwartz, 2000; Vignjevic et al., 2003; 2006 , Aratyn et al., 2007 ; and (2) the Rac-dependent, spatiallylocalised interaction of phosphofascin with active PKC that we report here and that is independent of Cdc42. Localised high levels of interacting fascin-PKCγ at the plasma membrane of migrating carcinoma cells may provide for a rapid cycling of fascin between the S39-phosphorylated and -unphosphorylated states that facilitates the effective local positioning and remodelling of filopodia and protrusions for directional migration. In view of the fact that Rac regulates both of these biochemical activities of fascin, and that high levels of phosphomimetic fascin inhibit cell migration and tumour development and metastasis (Hashimoto et al., 2007) , we propose that modulation of the Rac-to-fascin pathway and the phosphofascin-PKC complex could provide a novel, broadly applicable, biologically based strategy to limit carcinoma cell migration and metastasis.
Materials and Methods
Cells and materials
SW480, SW1222 and DLD-1 cell lines from human colonic adenocarcinomas were cultured in DMEM containing 10% FCS. SW480-Pa cells expressing Tet repressor and SW480 IKD-F11 cells, in which fascin 1 is inducibly knocked down by culture in 0.5 μg/ml doxycycline (Sigma) for 48 hours, were as described (Hashimoto et al., 2007) . The PKCγ-mRFP expression plasmid was prepared by subcloning cDNA for human PKCγ (GenBank clone BM926293, from Research Genetics) into pcDNA3.mRFPC, using the PCR primers 5ЈGTACAAGCTTGTT TCTGG -GGCCATGGCTGGT and 5ЈGTACGGATCCCATGACGGGCACAGGCACTGG. A constitutively active A25E mutant (Baier-Bitterlich et al., 1996) and the kinase-dead K380A mutant (Rosenberg and Ravid, 2006) were generated in this plasmid by PCRbased site-directed mutagenesis using the Quickchange II XL kit (Stratagene) according to manufacturer's instructions, with the PCR primer pairs 5ЈCAGAAAGGGGGAGCTGAGGCAGAAGGTG and 5ЈCACCTTCTGCCTCAG -CTCCCCCTTTCTG (for A25E), and 5ЈGAGCTCTACGCCATCGCGATCTTGAA -AAAGGAC and 5ЈGTCCTTT TT CAAGATCGCGATGGCGTAGAGCTC (for K380A). Expression plasmids for V12Rac1-HA, V12Cdc42-HA, N17Rac1-myc, N17Cdc42-myc, wild-type PAK1 and PAK1-AID were as described (Adams and Schwartz, 2000; Parsons et al., 2005) . pEGFP plasmids for expression of fascin 1 from H. sapiens or X. tropicalis were as described (Hashimoto et al., 2007) . BIM and NSC23766 were obtained from Calbiochem and PDBu from Sigma. Mouse monoclonal antibody to Rac1 was from Upstate. Antibodies to Pak1 and Pak1-T423-PO 4 were from Cell Signaling. Rac-GTP levels were measured by the G-LISA method (Cytoskeleton) according to manufacturer's procedures, using SW480 cells plated on 15 nM laminin for 2 hours in the absence or presence of 100 μM NSC23766. C2C12 cells plated for 15 minutes on 50 nM fibronectin were used as a positive control for the Rac-GTP assay. All measurements were carried out in triplicate. Fluorescence lifetime measurements by time-correlated singlephoton counting FLIM SW480 cells were transfected with expression constructs as stated using Fugene 6 transfection reagent and manufacturer's procedures (Roche). For fixed samples, cells were fixed in 4% paraformaldehyde and permeabilised in 0.2% (w/v) Triton X-100 in PBS. After quenching with 1 mg/ml sodium borohydride in PBS for 10 minutes at room temperature, cells were washed in PBS and mounted in Mowiol containing 2.5% DABCO (Sigma). For live time-domain fluorescence lifetime imaging microscopy (FLIM) experiments with randomly migrating cells, cells were plated following transfection onto 3 cm glass-bottom dishes coated with 15 nM laminin, allowed to adhere and migrate for 2 hours, and the media replaced with phenol red-free Optimem (Gibco) prior to imaging. In some experiments, cells were treated with inhibitors or activators using previously optimised dose and time conditions (Hashimoto et al., 2007) . Serum-starvation was started 24 hours after transfection and was carried out for 16 hours before fixation for FLIM. FLIM was performed with a multi-photon microscope system as described (for details, see Parsons et al., 2005; Peter et al., 2005) . Fluorescence lifetime imaging capability was provided by time-correlated single-photon counting electronics (Becker & Hickl, SPC 700). A 40ϫ objective was used throughout (Nikon, CFI60 Plan Fluor N.A. 1.3) and data were collected at 500±20 nm through a bandpass filter . Acquisition times of the order of 300 seconds at low 890 nm excitation power were used to achieve sufficient photon statistics for fitting, while avoiding either pulse pile-up or significant photobleaching.
Analysis of data for FRET experiments
Data were analysed as previously described (Parsons et al., 2005; Prag et al., 2007) . Briefly, bulk measurements of Forster resonance energy transfer (FRET) efficiency (i.e. intensity-based methods) cannot distinguish between an increase in FRET efficiency (i.e. the coupling efficiency) and an increase in FRET population (i.e. the concentration of FRET species) because the two parameters are not resolved. Measurements of FRET based on analysis of the fluorescence lifetime of the donor resolve this issue when analysed using multi-exponential decay models. For measurements of bulk interactions (i.e. where only single exponential decays are fit to the data), measured efficiencies will appear significantly lower owing to the assumption that all donors are associated with one or more acceptors. The assumption that non-interacting and interacting fractions are present allows the determination of the efficiency of interaction. The FRET efficiency is related to the molecular separation of donor and acceptor, and the fluorescence lifetime of the interacting fraction by:
where R 0 is the Förster radius, R the molecular separation, η fret is the lifetime of the interacting fraction and τ d the lifetime of the donor in the absence of acceptor. The donor-only control is used as the reference against which all other lifetimes are calculated in each experiment. η fret and τ d can also be taken to be the lifetime of the interacting fraction and non-interacting fraction, respectively. Quantification was made from all pixels within each cell analysed. All data were analysed using TRI2 software (developed by Paul Barber, Gray Cancer Institute, London, UK). Histogram data presented here are plotted as mean FRET efficiency from the stated number of cells over three experiments ± s.e.m. ANOVA was used to test statistical significance between different populations of data. Fig. 4B demonstrates the range of lifetime efficiencies per cell normalised for pixel intensity for each experimental condition. In the figures, lifetime images of representative cells are presented using a pseudocolour scale, whereby blue depicts normal GFP lifetime (no FRET) and red depicts lower GFP lifetime (areas of FRET).
Confocal microscopy
Confocal images were collected on a model LSM 510 Meta confocal laser-scanning microscope (Carl Zeiss) using a 63ϫ/1.4Plan-APOCHROMAT oil immersion objective. Fascin immunostaining was carried out with mouse monoclonal 55k2 (Dako). Expression of GTPases was detected with 12CA5 mouse monoclonal antibody to influenza haemagglutinin-tag (HA) (obtained from Cancer Research UK) or 9E10 mouse monoclonal to c-myc (Evan et al., 1985) . Species-specific FITC-, Cy3-or Cy5-tagged secondary antibodies were from ImmunoResearch Laboratories.
Analysis of PKCγ activation and PKCγ immunoprecipitation
The PKC isoforms expressed by colon carcinoma cells were identified by immunoblotting whole cell extracts with a panel of mouse monoclonal antibodies to the PKC family (BD Biosciences). For analysis of PKCγ activation, SW480 cells were treated with solvent, 1 μM BIM, 50 nM TPA or 100 μM NSC23766, under previously optimised conditions (Hashimoto et al., 2007) , lysed in RIPA buffer containing 1 μM Calyculin A (Calbiochem) and protease inhibitor cocktail (Boehringer Mannheim), and resolved by SDS-PAGE and western blotting. Blots were probed with anti-PKCγ-T655PO 4 (Upstate) or anti-PKCγ (Santa Cruz Biotechnology) antibodies and developed with anti-rabbit HRP-conjugated secondary antibody (Dako) and ECL (Pierce) on Kodak X-ray film. For PKCγ immunoprecipitation, protein A/G beads (Santa Cruz Biotechnology) were incubated with anti-PKCγ antibodies, washed and then incubated with RIPA cell lysates for 4 hours in the presence or absence of NSC23766 or BIM. After washing thoroughly, beads were boiled in sample buffer and analysed by SDS-PAGE and western blotting.
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